Literature DB >> 10081510

Human experimentation with Neisseria gonorrhoeae: progress and goals.

M S Cohen1, J G Cannon.   

Abstract

Infection with Neisseria gonorrhoeae has adverse consequences for reproductive health and facilitates the transmission of the human immunodeficiency virus. A major limitation in the development of gonococcal vaccines has been the lack of an animal model. Urethral infection can be initiated in male volunteer subjects through urethral inoculation. Several hundred patients have participated in studies using this experimental infection model. These studies have helped define the natural history of experimental infection and provided a better understanding of phenotypic and genotypic variation of gonococci in vivo. Isogenic molecular mutants can be used to define a role for gonococcal surface structures, including pilin and transferrin-binding proteins; recent results demonstrate that gonococci unable to express transferrin- and lactoferrin-binding proteins cannot cause urethral infection. The experimental model has proven to be an efficient means of studying gonococcal infection and focusing vaccine development. In addition, this model should allow vaccines to be tested quickly and efficiently.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10081510     DOI: 10.1086/513847

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  33 in total

1.  Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection.

Authors:  Stanley M Spinola; Cliffton T H Bong; Andrew L Faber; Kate R Fortney; Stacy L Bennett; Carisa A Townsend; Beth E Zwickl; Steven D Billings; Tricia L Humphreys; Margaret E Bauer; Barry P Katz
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

2.  The frequency and rate of pilin antigenic variation in Neisseria gonorrhoeae.

Authors:  Alison K Criss; Kimberly A Kline; H Steven Seifert
Journal:  Mol Microbiol       Date:  2005-10       Impact factor: 3.501

3.  Construction of prokaryotic expression plasmid of fusion protein including porin A and porin B of Neisseria gonorrhoeae and its expression in E. coli.

Authors:  Fang Liao; Qifa Song; Mufen Wan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

4.  Gonococci exit apically and basally from polarized epithelial cells and exhibit dynamic changes in type IV pili.

Authors:  Alison K Criss; H Steven Seifert
Journal:  Cell Microbiol       Date:  2006-09       Impact factor: 3.715

Review 5.  Focusing homologous recombination: pilin antigenic variation in the pathogenic Neisseria.

Authors:  Laty A Cahoon; H Steven Seifert
Journal:  Mol Microbiol       Date:  2011-08-04       Impact factor: 3.501

6.  Vaccines against gonorrhea: current status and future challenges.

Authors:  Ann E Jerse; Margaret C Bash; Michael W Russell
Journal:  Vaccine       Date:  2013-09-06       Impact factor: 3.641

7.  Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice.

Authors:  A E Jerse
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

8.  Altering the Neisseria gonorrhoeae pilE Guanine Quadruplex Loop Bases Affects Pilin Antigenic Variation.

Authors:  Lauren L Prister; Shaohui Yin; Laty A Cahoon; H Steven Seifert
Journal:  Biochemistry       Date:  2020-02-27       Impact factor: 3.162

9.  Resistance of Neisseria gonorrhoeae to non-oxidative killing by adherent human polymorphonuclear leucocytes.

Authors:  Alison K Criss; Ben Z Katz; H Steven Seifert
Journal:  Cell Microbiol       Date:  2009-03-12       Impact factor: 3.715

10.  Neisseria gonorrhoeae RecQ helicase HRDC domains are essential for efficient binding and unwinding of the pilE guanine quartet structure required for pilin antigenic variation.

Authors:  Laty A Cahoon; Kelly A Manthei; Ella Rotman; James L Keck; H Steven Seifert
Journal:  J Bacteriol       Date:  2013-03-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.